Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Prefest(Estradiol/Norgestimate)Teva Pharmaceutical Industries Limited logoTEVA

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Teva Pharmaceutical Industries Limited

$23K

Medicare cost, 2024

Medicare drug plans spent $23,195 on Prefest (estradiol/norgestimate) in 2024, for 66 prescriptions and refills filled by 46 patients. Spending fell 85% from 2023 to 2024. It is made by Teva Pharmaceutical Industries Limited (TEVA).

Medicare cost, 2024

$23K

-85.2% from 2023

Prescriptions

66

$351.44 per claim

Patients

46

47 prescribers

Total spending, 2024

$23K

$504.24 per patient

Questions and answers

How much does Medicare spend on Prefest?

Medicare prescription drug plans paid $23K for Prefest in 2024, for 66 prescriptions and refills to 46 patients (down 85.2% from 2023). The average cost per claim was $351.44.

Which state spends the most on Prefest?

California had the highest Medicare cost for Prefest in 2024: $3,684 for 11 claims.

Who makes Prefest?

Prefest is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Teva Women's He.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Prefest was $23K in 2024, after a high of $207K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022151455126$186K
2023109363100$157K
2024476646$23K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Teva Women's HeTEVA logoTEVA66$23K

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube